Responsibility First

RTI Biologics Announces 2012 First Quarter Results

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Schedules 2012 First Quarter Earnings and Conference Call for April 26, 2012

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Implements Recycling Initiative

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Report to the Ombudsman

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Highlights Biologic Implants, Public Education Website at 2012 AAOS Annual Meeting

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Announces 2011 Fourth Quarter, Full Year Results, 2012 Financial Guidance

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Schedules 2011 Fourth Quarter Earnings and Conference Call for Jan. 31, 2012

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Launches AllograftInfo.com Educational Website

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Achieves 98.7 Percent Equipment Performance Rating – Recognized In Evolution Magazine

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Releases Corporate Social Responsibility Report

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

A Message from our President and CEO

Corporate Social Responsibility

I am pleased to share with you RTI Biologics’ first corporate social responsibility report. This report is the culmination of a year’s worth of data collection, fact gathering and process evaluations.

Our strategy for corporate social responsibility is simple. If we live by our values of respect, commitment, diversity, innovation and integrity and incorporate those into all of our decisions, we will be acting in a manner that is not only best for our company, but for everyone our company impacts. Being a responsible corporate citizen is something we must do if we want to succeed as a company. It’s that simple.

Thank you for your interest in RTI Biologics, and I hope you enjoy our inaugural corporate social responsibility report.

Sincerely,
Brian K. Hutchison
President and CEO

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Announces 2011 Third Quarter Results

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Schedules 2011 Third Quarter Earnings and Conference Call for Oct. 27, 2011

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Celebrates 40 Years of Clinical Use of the Tutoplast® Sterilization Process

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Announces 2011 Second Quarter Results

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Schedules 2011 Second Quarter Earnings and Conference Call For July 28, 2011

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Announces Launch of New Meniscus Allograft Instrumentation

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Announces Launch of BioAdapt™ DBM Foam

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Rapid Response Communications

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Splits Chairman and CEO Roles

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Announces 2011 First Quarter Results

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Schedules 2011 First Quarter Earnings and Conference Call for April 28, 2011

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Announces Processing and Supply Agreement With Alphatec Spine

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Mission Statement

Mission

We improve lives by using the body to heal the body to achieve life-restoring results.

Vision

We will be recognized as the world leader in transforming donated and natural tissue into safe and innovative biologic solutions.

Values

Respect – We respect the gift of donation and honor the memories of our donors and their families by respecting each other, our community and our natural resources.

Commitment – We are committed to maximizing the gift of donated tissue. We hold each other accountable to deliver high quality, safe implants to our patients and positive financial results to our stakeholders. We operate with a sense of urgency in everything we do in order to meet our commitments to the constituencies we serve.

Diversity – We leverage the diversity of our people, strengths and ideas to achieve world-class results.

Innovation – We approach our work with the spirit of creativity and innovation.

Integrity – We earn the trust of those we serve by holding ourselves to the highest ethical standards.

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Announces 2010 Fourth Quarter, Year End Results

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Schedules 2010 Fourth Quarter, Year End Earnings and Conference Call for Feb. 3, 2011

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Announces 2010 Third Quarter Results

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Schedules 2010 Third Quarter Earnings and Conference Call for Nov. 4, 2010

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics and Athersys Announce Collaboration in the Orthopedic Market

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics and Zimmer Dental Enter Distribution Agreement for Global Biologic Implacts

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics, Medtronic Continue Strong Relationship

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Annouces 2010 Second Quarter Results

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Adds Dean H. Bergy to Board of Directors

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Announces 2010 Second Quarter Earnings and Conference Call

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Announces New Organization Structure

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Announces 2010 First Quarter Results

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Announces 2010 First Quarter Earnings and Conference Call

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Launches Reimbursement Hotline for Sports Medicine

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Launches Two Biologic Implants at Orthopaedic Surgeon Annual Meeting

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

$250,000 Grant Awarded for Groundbreaking Ligament and Tendon Repair Research

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Donates Matrix HD(tm) For Surgeries in Haiti

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Announces 2009 Year End, Fourth Quarter Results, Estimates 2010 Revenues And EPS

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Donates Matrix HD™ To Treat Young Child With Rare Genetic Skin Condition

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Announces 2009 Fourth Quarter and Year End Earnings and Conference Call

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Adds Blakely, LaPrade To Leadership Team

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Donates Allograft Implants for Children with Physical Disabilities in Kijabe, Kenya

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Florida Resident to Honor Mother’s Life During the Rose Bowl Parade

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Electronic I.R. Kit

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Honored with BioFlorida’s 2009 Gury Company of the Year Award

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Announces 2009 Third Quarter Results

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Wendy Crites Wacker, APR

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Donor Criteria Brochure

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Patient Safety Through Redundant Safeguards Brochure

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Patient Brochure

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

2009 Third Quarter Earnings And Conference Call

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics Receives 2009 Gainesville Area Chamber of Commerce Business Award for Expansion

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Receives 2009 Governor’s Business Award for Expansion

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Announces 2009 Second Quarter Results

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Distribution and Supply Agreement Expanded with Davol for Tutoplast® Sterilized Dermal Allografts

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

2009 Second Quarter Earnings and Conference Call

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Standards for sterility

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Microorganism

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Sterilization

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Sterility

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Aseptic processing

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Sterile

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Autograft

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Xenograft

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Aseptic

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Allograft

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Are all allografts sterile?

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

How safe are allograft implants?

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

How do you ensure that donors of allograft tissues do not have infections that can be transmitted?

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Where can I learn more about tissue donation?

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

How do I make the decision to use allograft for my surgical procedure?

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Is there a chance of rejection from allograft implants?  Will I have to take anti-rejection drugs?

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

How long does an allograft last?

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

How are the tissues prepared for implantation?

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

What laws and regulations govern the recovery, processing and distribution of tissues in the U.S.?

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

How are the tissues recovered?

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

What is the process of tissue donation, from recovery to implantation?

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

What are the benefits of using allograft tissue?

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Where do allografts come from?

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Contact Us

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Terms of Use

This web site is owned and maintained by RTI Biologics™. By accessing web site pages belonging to or operated by RTI Biologics™, you agree to abide by the terms and conditions set forth in this notice (hereafter referred to as “Terms of Use”). We may change these Terms of Use at any time. In using or downloading information from this web site, you agree to the most recent version of the Terms of Use. Please review the Terms of Use each time you visit this web site. These Terms of Use were last updated on December 3, 2009.

CALL 911 FOR AN EMERGENCY.
THIS WEB SITE DOES NOT PROVIDE MEDICAL ADVICE. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY.

Content

The use of this web site and the content therein is permitted for private, non-commercial use. The information contained in this web site is for informational purposes only and shall not be understood as or substituted for legal or medical advice. This web site and the contents herein are provided as a convenience to you. RTI Biologics™ will make reasonable efforts to ensure the information provided on this web site is accurate and complete. However, the contents of this web site are provided on “as is” and “as available basis.” RTI Biologics™ makes No Warranties or Representations of Any Kind, either expressed or implied, as to the availability, accuracy, completeness, or reliability of the content of this web site. RTI Biologics™ shall not be liable for any damages or injury of any kind resulting from users’ access to or inability to access this web site or from reliance on any information at this web site. In jurisdictions that do not allow exclusion of certain warranties or limitations of liability, the liability of RTI Biologics™ would in such case be limited to the greatest extent permitted by law.

Developments regarding health information are continuous. Therefore, it is always best to confirm information with your health care professional.

Copyrights and Trademarks

The materials on this web site belong to and are licensed to RTI Biologics™. The contents of this web site are protected by appropriate copyright and trademark laws. Any rights not expressly granted herein are reserved. By using the information provided on this web site, the user agrees to abide by and comply with all applicable copyright and trademark laws. Reproduction, transfer, distribution or storage of part or all of the contents in any form without the prior written permission of RTI Biologics™ is prohibited except in accordance with the terms provided herein.

Authorized Use

RTI Biologics™ authorizes, subject to conditions provided herein, the user’s personal, non-commercial use to view, download, email and print copies of the information provided on this web site (hereinafter in this paragraph referred to as “Information”). Unless consent is otherwise provided in writing by RTI Biologics™, the authorized use of Information is subject to the following conditions:

  1. Information is for personal use only and is not to be used for any public or commercial purpose;
  2. Information may not be altered, reproduced, or redistributed;
  3. Information should not be given to any other person without that person having notice and acceptance of the terms and conditions of use contained herein;
  4. Information that is downloaded, emailed, or printed must retain any and all copyright and other proprietary notices contained within the Information, including any copyright notice located in headers or footers of the page.

The authorization to use information provided on this web site does not transfer title in the information to the user and does not grant the user any express or implied right under any patents, trademarks, copyrights, trade secrets or other proprietary information.

Individual materials on this web site may be subject to additional terms indicated within those materials. In viewing, downloading, emailing, or printing information, you agree to abide by any and all terms provided within the individual materials in addition to the terms provided herein.

Product Information

This web site contains information about products approved and cleared for use in the United States. Although accessible by others, products may or may not be available outside of the United States or may be available under different trademarks in different countries. The products may be approved or cleared by governmental regulatory organizations for sale or use with different indications or restrictions in different countries. Products may not be approved for use in all countries. Nothing on this web site should be construed as a promotion or solicitation for any product or for the use of any product in a particular way which is not authorized under the laws and regulations of the country where the reader is located. Specific questions physicians may have about the availability and/or use of products located on this web site should be directed to their particular local sales representative. Specific questions patients may have about the availability, use, and/or appropriateness of the products on this web site should be directed to their own health care provider.

Medical Information and Surgical Implantation

This web site may contain from time to time general information related to various medical conditions and their treatment. However, this information is intended for informational purposes only. This information is in no way intended to be used in the diagnosis or treatment of any health condition. Such information is not meant to be a substitute, and users of this web site should never substitute, for the advice provided by a physician or other medical professional. You should always consult a professional medical adviser, such as a physician to determine what courses of treatment, if any, may be appropriate for you.

The surgical implantation diagrams presented on this web site are intended for general demonstration purposes only, and are not intended to be an endorsement or critique of a particular surgeon’s practice. RTI Biologics™ is the manufacturer of the implantation and/or medical devices presented on this web site. RTI Biologics™ does not practice medicine and does not recommend or endorse any surgical techniques for use. It is solely the responsibility of each individual patient’s physician to select and utilize the appropriate surgical methods to address the patient’s particular needs. RTI Biologics™ is not responsible for the selection of the appropriate surgical technique to be utilized for a particular patient and his/her individual needs.

Third Party Links and Information

For your convenience, this web site may provide external links to web sites on the internet that are owned and/or operated by third parties over whom RTI Biologics™ has no control. RTI Biologics™ is not responsible for the content of such other web sites. RTI Biologics™ makes no warranty or representation as to the availability, accuracy, completeness, or reliability of the content contained on these third party web sites and shall have no liability for any damages of any kind arising from such content. By linking to a third-party web site through this web site, or by accessing this website through a third party web site, you agree that RTI Biologics™ has no control over the content of such third party web site and cannot assume any responsibility for content within such third-party web sites. The inclusion of these third party web site links does not in any way constitute a recommendation or endorsement by RTI Biologics™ for the use of a particular web site or the use of any particular product or service contained within those web site links.

Non-Confidential Information

RTI Biologics invites your feedback, comments, and ideas. However, any communication or other material sent to RTI Biologics™ servers, including, but not limited to questions, comments, suggestions or the like, is and will be deemed to be non-personal, non-confidential, and non-proprietary. RTI Biologics™ shall have no obligation of any kind with respect to such information. By submitting material to any of RTI Biologics™ servers you agree:

  1. that you are the lawful owner of the material or otherwise have a legal right to distribute the material and grant unrestricted use of the material to RTI Biologics™; and
  2. the material is not unlawful or otherwise unfit for publication by RTI Biologics™.

If you transmit to RTI Biologics severs any ideas, concepts, know-how or techniques, you hereby grant RTI Biologics™ unrestricted use of such information for any purpose whatsoever. You agree not to take action against RTI Biologics™ in relation to any communications or material that you submit and you agree to indemnify RTI Biologics™ if any third party takes action arising out from your submission of material.

Forward-Looking Statements

This web site contains forward-looking statements that may express plans, goals, targets, future development, and otherwise are not historical statements of fact regarding RTI Biologics™ financial and operating performance, business plans, business prospects, and products. Identifiable language that may indicate a forward-looking statement includes, but is not limited to, “expect,” “may,” “goal,” “should,” “plan,” “believe,” “target,” “continue,” “will,” “aim,” “anticipate,” and “estimate.” However, this list is in no way exhaustive.

These forward-looking statements are based on our current expectations about future events and therefore are subject substantial risks and uncertainties due to unpredictably economic, political, and regulatory restrictions that may impact RTI Biologics™. These risks and uncertainties may cause actual results to differ materially from the expectations and projections set forth explicitly or implicitly in such forward-looking statements. A further explanation of the certain risks and uncertainties are set forth in RTI Biologics reports on Form 8-K, 10-Km and 10-Q filed with the U.S. Securities and Exchange Commission (“SEC”).

RTI Biologics™ undertakes no obligation to update or revise forward-looking statements, the statements made herein, or the risk factors that may relate thereto as a result of new information, future events or developments, or otherwise.

Investor Information

You should not rely on the stock price information on our web site. Although we believe the information is accurate, you should not rely on the stock price information for investment purposes. RTI Biologics™ does not generate the information regarding its stock price; therefore, we cannot guaranty the accuracy, completeness, or reliability of the information. RTI Biologics™ is not liable for any loss or damages that arise from reliance on the stock price information located within this web site.

This web site does not provide investing advice. Material on this website regarding investment information, including but not limited to, our SEC filings and stock price is for informational purposes only. Nothing in this web site constitutes investment advice or offers to sell or by security. RTI Biologics™ cannot guarantee the future performance of the stock market and its stock. Important information can be located in our latest annual report, 10-K, 10-Q, and 8-K reports to the SEC over the past year as well as our recent proxy statements for shareholder meetings. A variety of public materials are also available about RTI Biologics™ and the Industry. If you are interested in investing in RTI Biologics™ we strongly urge you to educate yourself as an investor.

Indemnification

You agree to indemnify, defend, and hold harmless RTI Biologics™, it officers, directors, employees, agents, suppliers, and third party partners from all losses, expenses, damages and costs, including reasonable attorneys’ fees arising out of any third-party claims based on or relating to your use of this web site or your violation these Terms of Use.

Severability

These Terms of Use is intended to be severable. If any provision of this agreement is held to be invalid or unenforceable, then such provision shall be severable without affecting the enforceability of all remaining provisions.

Governing Law

This Terms of Use Agreement and your use of this web site shall be governed by the federal laws of the United States of America and the State of Florida, without respect to its conflict of laws principles. By using this web site, you agree that any legal action or proceeding related to this web site and the information contained herein shall be brought exclusively in a federal or state court of competent jurisdiction and venue sitting in the State of Florida.

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI Biologics offers a competitive benefits package for its employees. For additional benefit information contact the Human Resources Department at 1-877-343-6832 ext. 4143.

Benefits Overview

Health Insurance

RTI offers full-time employees (30 hours or more) comprehensive health insurance coverage through Blue Cross Blue Shield of Florida. We offer two plans to choose from each with four levels of coverage. RTI pays a significant portion of the premium for any of the selected coverage levels. Pre-tax deductions are withheld bi-weekly through payroll deduction and coverage begins the first of the month following the employee’s date of hire. The rates are as follows:

Health Insurance Rates

Coverage Level BlueOptions 3769 BlueOptions 3160/3161
Employee $ 19.59 $ 0.00
Employee + Child(ren) $ 83.85 $ 27.86
Employee + Spouse $ 115.19 $ 68.44
Family $ 181.79 $ 82.08

Dental Insurance

RTI offers three levels of dental coverage to choose from. RTI pays a significant portion of the premium for any of the selected coverage levels. Many diagnostic and preventative services are covered at no charge. Other services such as crowns and orthodontia require co-payments. Some pre-existing conditions are not covered until coverage has been in force for twelve (12) months. For employees located in Florida, a participating plan dentist should be selected in order to obtain the maximum benefit from the plan. Employees not residing in Florida may select the dentist of their choice. Pre-tax deductions are withheld bi-weekly through payroll deduction and coverage begins the first of the month following the employee’s date of hire. The rates are as follows:

Dental Insurance Rates

Coverage for Cost
Employee $ 3.50
Employee + 1 $ 15.65
Family $ 29.67

Basic Life Insurance

RTI provides $50,000 of coverage for natural death and $100,000 for accidental death at no cost to the employee. The coverage also provides dismemberment benefits.

Voluntary Life Insurance

This plan allows employees to purchase additional amounts of life insurance coverage on himself/herself and on each eligible dependent(s). The maximum coverage available for the employee is $500,000, the maximum available for spousal coverage is $100,000, and for each child the maximum available is $10,000. Any amounts applied for that exceed $140,000 will require approval by the carrier.

Short Term Disability Insurance

This benefit provides partial income replacement (60.00% of base earnings, up to $800 per week) beginning on the 15th day of absence due to illness or non-work related injury for a maximum period of 11 weeks. RTI fully covers the cost of this benefit.

Long Term Disability Insurance

This benefit provides partial income replacement (66.67% of base earnings, up to $8,000/month) after the short-term disability benefits cease. Benefits can be payable up to age 65. RTI fully covers the cost of this benefit.

Section 125 – Cafeteria Plan

Employees have the opportunity to pay for dependent care expenses and qualified medical and dental expenses with pre-tax dollars. These flexible spending accounts are approved and governed by the Internal Revenue Service guidelines. Employees can only make changes during the year if a qualifying event occurs. Any deposits not used within the calendar year are forfeited.
Dependent Care Maximum $5,000/year
Medical Reimbursement $3,000/year

Voluntary Vision Plan

This plan provides a benefit option that covers all routine eye care including exams, eyeglasses and contact lenses. Single and family coverage is available. To obtain the maximum benefit from this plan the participant must select a providing physician. Pre-tax deductions are withheld bi-weekly through payroll deduction. The rates are as follows:

Vision Rates

Coverage for Cost
Employee $ 3.00
Family $ 8.59

Ancillary Voluntary Benefit Plan

Allstate offers insurance policies to help supplement primary health insurance plans by providing direct-to-the-policyholder cash benefits, to fill the gaps in traditional health insurance coverage, such as deductibles, out-of-pocket expenses and loss of earning power. All levels of coverage are payroll deducted on a pre-tax basis with the exception of disability insurance. Premiums are paid 100 percent by the employee.

Pet Assure

Pet Assure is the preferred alternative to insurance coverage for your family pet. Unlike pet insurance, all pets are covered; regardless of age, medical condition or any pre-existing condition. There are no exclusions, no deductibles and no waiting for reimbursement. Premiums are paid 100 percent by the employee.

Prepaid Legal and Identity Theft

The Identity Theft Shield program protects you and your family members against the five most common forms of identity theft: driver’s license, social security, medical, character/criminal and financial. The Legal Shield gives you and your family 24 hour access to legal consultation if you are detained, for only $1 a month – as an additional benefit to your family plan.

Prepaid Legal & Identity Theft Rates

Coverage for Cost
Identity theft & legal coverage $11.95
Identity theft only $5.98
Legal plan only $7.36

Retirement Savings Plan (401(k) Plan)

The 401(k) plan allows employees to set aside a portion of their salary and defer income taxes on savings. Employees are eligible to participate in the plan after 3 months of employment. RTI will match a portion of each employee’s contribution. Employees are 100-percent vested in the employer contributions after 3 years of employment.

Tuition Reimbursement Plan

RTI provides financial support to employees for education which leads to improvement of skills or other knowledge, which are directly related to a work position at RTI. Tuition reimbursement is available after one year of service for full-time employees for courses taken for credit, which are successfully completed at an accredited college or university.

Employee Assistance Program

RTI offers an Employee Assistance Program (EAP) to all employees at no cost to the employee. This program provides confidential counseling to employees and their family members.

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

RTI is committed to providing safe, high quality allografts and xenografts for use in spine, sports medicine, orthopedic, dental and other specialty surgeries.

Surgeons

RTI’s innovations continuously raise the bar of science and safety for biologics – from being the first company to offer precision-tooled bone implants and assembled technology to maximize each gift of donation, to inventing fully validated sterilization processes that include viral inactivation steps.

These processes – the BioCleanse® Tissue Sterilization Process, Tutoplast® Tissue Sterilization Process and Cancelle™ SP DBM Sterilization Process – sterilize tissue and are scientifically proven to address donor-to-recipient disease transmission risk while preserving tissue strength and biocompatibility. These processes have a proven record of more than two million implants distributed with zero incidence of allograft-associated infections.

My Biologics

My Biologics is a tool designed to help surgeons and medical facility representatives find information about RTI Biologics’ allografts and xenografts. My Biologics also has information about our sterilization processes, BioCleanse®, Tutoplast® and Cancelle™ SP. This site is available exclusively for existing customers.

Site Highlights:

  • Download or order more patient brochures directly from RTI
  • Download graft images and animations
  • Access detailed implant information
  • Download marketing literature and brochures, journal articles and white papers
  • Find customer service and rep contact information

Getting started is easy…

Register as a new user at www.mybiologics.com. You will receive an e-mail confirming your account has been created.

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Urological Procedures

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Meniscal Replacement

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Midfoot Fusion

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Joint Reconstruction

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Periprosthetic Fracture

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Ankle Fusion

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Shoulder Repair

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

High Tibial Osteotomies (HTO)

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Cartilage Restoration

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Soft Tissue Repair Augmentation

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Ophthalmological procedures

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Dental/Oral Maxillofacial Procedures

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Ligament Repair

Stock Ticker

Current Stock Info

» Price: 3.60

» Change: -0.08

» Last Update: 4:00pm

Download Investor Relations Kit

Report to The Ombudsman

Subscribe to Email Updates

Stay Informed, subscribe to our news list.

Subscribe Now...